By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.
I agree
Search Trends
SITEMAP
Copyright © 2024 CGTN. 京ICP备20000184号
Disinformation report hotline: 010-85061466
SITEMAP
Copyright © 2024 CGTN. 京ICP备20000184号
Disinformation report hotline: 010-85061466
AstraZeneca, one of the world's leading pharmaceutical companies, invested $700 million for an inhaled medicines manufacturing site in Qingdao City, Shandong Province last year. The investment has shown the British biopharmaceutical giant's commitment to the Chinese market, as its executive vice president Leon Wang stated in an interview with CGTN host Lincoln Humphries that "China is the best location for innovation".